miR-203a-3p was determined to target THBS2 to inhibit colorectal cancer progression and metastasis; thus, miR-203a-3p may be considered a potentially novel approach to treating colorectal cancer [113]. The gene discussed is THBS2; the disease is colorectal cancer.